Shelf-life Extension for the Pfizer Pediatric Vaccine
| Having trouble viewing this email? View it as a Web page. |
![]() |
Shelf-life Extension for the Pfizer Pediatric Vaccine |
||||||||||||||||||||
|
FDA has approved a shelf-life extension for the Pfizer Pediatric vaccine (Orange cap, 5-11 YO, diluent required) and the soon to be available Adol/Adult Tris (Gray Cap, age 12+, no diluent). This approval may be found at Healthcare Providers for 5-11 years of age, orange cap (must dilute) (fda.gov) ; Healthcare Providers for 12 years of age and older, gray cap (no dilution) (fda.gov) ) and takes effect immediately. This extension applies to frozen (ULT) inventories only. The date printed on the Pfizer Pediatric (orange cap) and Adult/Adolescent (gray cap, 12+, no diluent) vaccine vials indicate the manufacture date and NOT the expiration date. Originally, the expiration date was 6 months from the manufacture date. The expiration date for Pfizer orange and gray cap vaccine has now been extended to 9 months (while held at ULT frozen.) The Fact Sheets for both orange and gray cap vials provided by the FDA now reads, “regardless of storage conditions, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons”. The updated expiry dates for both the orange and gray cap vials based on 9 months from the date of manufacture are provided below.
*Date of expiration always falls on the last day of the month The QR code provided on the Pfizer Pediatric Vaccine carton provides a link to the EUA but does not provide information on expiration dates. Please follow EUA recommendations for storage: Pfizer 5 through 11 years of age formulation
Pfizer 12 years and older formulation.
Regardless of storage condition, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons. All Pfizer updated Fact Sheets may be found at:
Healthcare provider questions regarding COVID-19 vaccine can be directed to the COVID-19 Vaccine Call Center at 1-800-831-6293 ext. 1 or emailed to COVID19Vaccine@idph.iowa.gov.
|
||||||||||||||||||||
| You are subscribed to IBPE_News, Events and Press Releases for Iowa Board of Pharmacy. There are new Press Releases available for your review. |
